MDMA ('ecstasy') enhances basal acetylcholine release in brain slices of the rat striatum

European Journal of Neuroscience

Volumn 12, Issue 4, 2000, Pages 1385-1390

  Fischer, H S ^a   Zernig, G ^a   Schatz, D S ^a   Humpel, C ^a   Saria, Alois ^a  

^a Neurochemistry Unit   (Austria)

Author keywords

Acetylcholine; In vitro; MDMA; Release; Striatum

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ACETYLCHOLINE; CALCIUM ION; DOPAMINE 2 RECEPTOR BLOCKING AGENT; GLUTAMATE RECEPTOR ANTAGONIST; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR ANTAGONIST; MUSCARINIC RECEPTOR BLOCKING AGENT; SEROTONIN 1 ANTAGONIST; SEROTONIN 2 ANTAGONIST; SEROTONIN 3 ANTAGONIST; TETRODOTOXIN;

ACETYLCHOLINE RELEASE; ANIMAL TISSUE; ARTICLE; BRAIN PERFUSION; BRAIN SLICE; CONTROLLED STUDY; CORPUS STRIATUM; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ACETYLCHOLINE; ANIMALS; ANTIPARKINSON AGENTS; CORPUS STRIATUM; DIPHENHYDRAMINE; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; HISTAMINE H1 ANTAGONISTS; MALE; METHYSERGIDE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PYRILAMINE; QUINOXALINES; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN AGENTS; SEROTONIN ANTAGONISTS; TRITIUM;

EID: 0034090539     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.2000.00004.x     Document Type: Article

References (48)

1. Battaglia, G., Brooks, B.P., Kulsakdinun, C. & DeSouza, E.B. (1988) Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites. Eur. J. Pharmacol., 149, 159-163.
2. 1 radioligand [3H]-(-)-trans-1-phenyl3-aminotetralin. Brain Res., 837, 95-105.
3. 125I]Iodobolpyramine. Neuroscience, 26, 553-600.
4. Bristow, L.J. & Bennet, G.W. (1988) Biphasic effects of intra-accumbens histamine administration on spontaneous motor activity in the rat; a role for central histamine receptors. Br. J. Pharmacol., 95, 1292-1302.
5. Chiavegatto, S., Nasello, A.G. & Bernardi, M.M. (1998) Histamine and spontaneous motor activity: biphasic changes, receptors involved and participation of the striatal dopamine system. Life Sci., 62, 1875-1888.
6. Damsma, G., Lammerts van Bueren, D., Westerink, B.H.C. & Horn, A.S. (1987) Determination of acetylcholine and choline in the femtomol range by means of HPLC, a postcolumn enzyme reactor and electrochemical detection. Chromatographia, 24, 827-831.
7. Dragunow, M., Logan, B. & Laverty, R. (1991) 3,4-Methylenedioxymethamphetamine induces Fos-like proteins in rat basal ganglia: reversal with MK801. Eur. J. Pharmacol., 206, 255-258.
8. 1 receptor blockade. Naunyn-Schmiedeberg's Arch. Pharmacol., 358, 423-429.
9. 2+. J. Neurochem., 52, 1680-1685.
10. Finnegan, K.T., Skratt, J.J., Irwin, I. & Langston, J.W. (1990) The N-methyl-D-aspartate (NMDA) receptor antagonist, dextorphan, prevents the neurotoxic effects of 3,4-methylenedioxymethamphetamine (MDMA) in rats. Neurosci. Lett., 105, 300-306.
11. Finnegan, K.T. & Taraska, T. (1996) Effects of glutamate antagonists on methamphetamine and 3,4-methylenedioxymetamphetamine-induced striatal dopamine release in vivo. J. Neurochem., 66, 1949-1958.
12. Fitzgerald, J. & Reid, J.J. (1993) Actions of methylenedioxymetamphetamine on monoamine transmitter release mechanisms in rat brain slices. Naunyn-Schmiedeberg's Arch. Pharmacol., 347, 313-323.
13. 1 receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 347, 50-54.
14. 2 receptors in the cAMP responses in guinea pig brain slices: effects of phorbol esters and calcium. Mol. Pharmacol., 33, 38-43.
15. Gillet, G., Ammor, S. & Fillion, G. (1985) Serotonin inhibits acetylcholine release from rat striatum slices: evidence for a presynaptic receptor-mediated effect. J. Neurochem., 45, 1687-1691.
16. Green, R.A., Cross, A.J. & Godwin, G.M. (1995) Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or 'ECSTASY'). Psychopharmacology, 119, 247-260.
17. 2 receptor agonists. Eur. J. Pharmacol., 264, 325-330.
18. Herrera-Marschitz, M., Goiny, M., Utsumi, H., Ferre, S., Guix, T. & Ungerstedt, U. (1990) Regulation of cortical and striatal dopamine and acetylcholine by glutamate mechanisms assayed in vivo with microdialysis: in situ stimulation with kainate-, quisqualate-and NMDA-receptor agonists. In Lubec, G. & Rosenthal, G.A. (eds), Amino Acids. Escom, Leiden, pp. 599-604.
19. Herrera-Marschitz, M. (1991) Modulation and striatal dopamine and acetylcholine release by different glutamate-and NMDA-receptor agonists. In Bernardi, G., Carpenter, M.B., Di Chiara, G., Morelli, M. & Stanzione, P. (eds), Basal Ganglia III. Plenum, New York, pp. 357-362.
20. Hollingthworth, W.B. & Daly, J.W. (1985) Accumulation of inositol phosphates and cyclic AMP in guinea pig cerebral cortical preparations. Effects of norepinephrine, histamine, carbamylcholine and 2-chloroadenosine. Biochem. Biophys. Acta, 847, 207.
21. Jackson, D., Stachowiak, M.K., Bruno, J.P. & Zigmond, M.J. (1988a) Inhibition of striatal acetylcholine release by endogenous serotonin. Brain Res., 457, 259-266.
22. Jackson, D., Bruno, J.P., Stachowiak, M.K. & Zigmond, M.J. (1988b) Inhibition of striatal acetylcholine release by serotonin and dopamine after the intracerebral administration of 6-hydroxydopamine to neonatal rats. Brain. Res., 457, 267-273.
23. James, M.K. & Cubeddu, L.X. (1987) Pharmacological characterization and the functional role of muscarinic autoreceptors in the rabbit striatum. J. Pharmacol. Exp. Ther., 240, 203-215.
24. 3H]dopamine release from superfused rat brain slices. Eur. J. Pharmacol., 132, 269-276.
25. Khateb, A., Fort, P., Pegna, A., Jones, B.E. & Mühlethaler, M. (1995) Cholinergic nucleus basalis neurons are excited by histamine in vitro. Neuroscience, 69, 495-506.
26. Koch, S. & Galloway, M.P. (1997) MDMA induces dopamine release in vivo: role of endogenous serotonin. J. Neural. Transm., 104, 135-146.
27. McKenna, D.J. & Peroutka, J. (1990) Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'). J. Neurochem., 54, 14-22.
28. Nash, J.F. (1990) Ketanserin pretreatment attenuates MDMA-indued dopamine release in the striatum as measured by in vivo microdialysis. Life Sci., 47, 2401-2408.
29. Nash, J.F. & Yamamoto, B.K. (1992) Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine. Brain Res., 581, 237-243.
30. 1-receptors in the rat brain: an autoradiographic study. Neuroscience, 6, 15-37.
31. Paxinos, G. & Watson, C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, Sydney.
32. Prast, H. & Philippu, A. (1992) Release of endogenous acetylcholine in the hypothalamus of conscious rats. Naunyn-Schmiedeberg's Arch. Pharmacol., 346, 1-3.
33. 2 histamine receptors. Naunyn Schmiedeberg's Arch. Pharmacol., 360, 552-557.
34. Rudnick, G. & Wall, S.C. (1992) The molecular mechanism of 'ecstasy' [3,4-methylenedioxymethamphethamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release. Proc. Natl Acad. Sci., 89, 1817-1821.
35. +-channels. Eur. J. Pharmacol., 343, 193-200.
36. Scatton, B. & Lehmann, J. (1982) N-Methyl-D-Aspartate-type receptors mediate striatal acetylcholine release evoked by excitatory amino acids. Nature, 297, 422-424.
37. Schatz, D.S., Kaufmann, W.A., Schuligoi, R., Humpel, C. & Saria, A. (2000) 3,4-Methylenedioxymethamphetamine ('ecstasy') induces c-fos like protein and mRNA in rat organotypic dorsal striatal slices. Synapse, 36, 75-83.
38. Schmidt, C.J., Levin, J.A. & Lovenberg, W. (1987) In vitro and in vivo neurochemicai effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain. Biochem. Pharmacol., 36, 747-755.
39. Schmidt, C.J., Sullivan, C.K. & Fadayel, G.M. (1994) Blockade of striatal 5-hydroxytryptamine-2 receptors reduces the increase in extracellular concentrations of dopamine produced by amphetamine analogue 3,4-methylenedioxymethamphetamine. J. Neurochem., 62, 1382-1389.
40. Smith, A.D. & Bolam, J.P. (1990) The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurons. Trends Neurosci., 13, 259-271.
41. Sonsalla, P.K., Nicklas, W. & Heikkila, R.E. (1989) Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. Science, 243, 398-400.
42. Steinbusch, H.W.M., Sauren, Y., Groenewegen, H., Watanabe, T. & Mulder, A.H. (1986) Histaminergic projections from the premammillary and posterior hypothalamic region to the caudate-putamen complex in the rat. Brain Res., 368, 389-393.
43. Stoof, J.C., Drukarch, B., DeBoer, P., Westerink, B.H.C. & Groenewegen, H.J. (1992) Regulation of the activity of striatal cholinergic neurons by dopamine. Neuroscience, 47, 755-770.
44. Wada, H., Inagaki, N., Yamatodani, A. & Watanabe, T. (1991) Is the histaminergic neuron system a regulatory center for whole-brain activity ? Trends Neurosci., 14, 415-418.
45. Yamamoto, B.K. & Spanos, L.J. (1988) The acute effects of methylenedioxymethamphethamine on dopamine release in the awake-behaving rat. Eur. J. Pharmacol., 148, 195-203.
46. Yamamoto, B.K., Nash, J.F. & Gudelsky, G.A. (1995) Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra. J. Pharmacol. Exp. Ther., 273, 1063-1070.
47. Yeh, S.Y., Dersch, C., Rothman, R. & Cadet, J.L. (1999) Effects of antihistamines on 3,4-methylenedioxymethamphetamine-induced depletion of serotonin in rats. Synapse, 33, 207-217.
48. Zaczek, R., Hurt, S., Culp, S. & DeSouza, E.B. (1989) Characterization of brain interactions with methylenedioxyamphetamine and methylenedioxymethamphetamine. NIDA Res. Monogr., 94, 223-239.